4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001963544-25-000004
Director bought 533,617 shares at $18.74 ($9,999,983)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Xia Yu Director | 2025-10-21 | Purchase | +533,617 | $18.74 | $9,999,983 | 32,057,147 | I: show line 1 in the form |
| Open-market purchases · 533,617 sh · avg $18.74 · $9,999,983 | |||||||
Loading xslF345X05/wk-form4_1761267986.xml…